Gregory Redpath

Dr. Gregory Redpath is a postdoctoral research fellow at the Department of Molecular Medicine, University of New South Wales, focusing on receptor trafficking and its role in human diseases and treatments. His work bridges cell biology, serotonin signaling, and endosomal recycling, particularly investigating how psychedelics interact with serotonin receptors and how lipoproteins are cleared via endocytosis.

Education:

• Ph.D. in Medicine (2011-2015), University of Sydney
• B.Sc. (Hons) in Biochemistry (2007-2010), University of Otago

Research interests:
Dr. Redpath's research integrates live cell imaging and cellular signaling to unravel mechanisms of receptor trafficking, endosomal recycling, and serotonin regulation. His work spans neuropharmacology (e.g., antidepressant effects on lipoprotein uptake) and immunology (e.g., T cell activation via receptor recycling). Key trends in his publications highlight endocytosis, membrane repair, and organelle dynamics.

Scientific awards:

• 2022: Future Leader to Watch, Biology Open
• 2018: Runner-up, Best Postdoctoral Presentation (Australia/New Zealand Society for Cell and Development Biology)
• 2014: David Walsh Prize for Best Student Presentation, ComBio
• 2010: Health Sciences Prestigious Summer Scholarship
• 2009: Health Research Council Summer Scholarship (New Zealand)

Supervision: He mentors multiple Ph.D. and Honours students, including Jack Zhang, David Kim, and Shreya Boby, while previously advising Halima Siddiqui and Manuela Ecker.